相关实验视频

Updated: Jul 4, 2025

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

痛风对心血管疾病死亡率的影响:元分析

Jielin Yuan¹, Zhitao Xie¹, Bo Pan¹

¹The Second Nanning People's Hospital, The Third Affiliated Hospital of Guangxi Medical University, No.13 Dancun Road, Jiangnan District, 530031, Nanning, Guangxi Zhuang Autonomous Region, China.

Zeitschrift fur Rheumatologie

|February 1, 2024

概括

痛风患者因心血管疾病 (CVD),包括冠心病 (CHD) 和心肌梗塞 (MI) 的死亡风险显著增加. 这一元分析证实了痛风与心血管疾病死亡率增加之间的强烈关联.

科学领域:

心脏病学心脏病学
类风湿病学类风湿病学
流行病学流行病学

背景情况:

关于痛风和心血管疾病 (CVD) 死亡率之间的关联,存在相互矛盾的流行病学数据.
一些研究表明,痛风患者的风险更高,而另一些研究则没有明确的联系.
这项研究旨在澄清患有痛风的个体中心血管疾病死亡率的相对风险.

研究的目的:

调查痛风和心血管疾病 (CVD) 死亡率之间的关联.
与健康对照人群相比,量化痛风患者心血管疾病死亡的相对风险.

主要方法:

在主要的科学数据库 (Google Scholar,PubMed,Web of Science) 中对2023年3月之前发表的研究进行了全面的文献搜索.
进行了一项元分析,总结了痛风对心血管疾病死亡率的影响.
使用STATA 12.0软件分析了危险比率 (HR) 和95%置信区间 (CI).

主要成果:

痛风患者表现出显著更高的心血管疾病死亡风险 (HR 1.30,95% CI 1.15-1.48).
冠心病 (CHD) 死亡率的风险也较高 (HR 1.28,95% CI 1.12-1.46).
观察到心肌梗塞 (MI) 死亡率的统计显著增加风险 (HR 1.13,95% CI 1.00-1.27).

结论:

这一元分析提供了强有力的证据,将痛风与心血管疾病死亡风险明显增加联系起来.
与没有痛风的患者相比,患有痛风的患者面临的整体心血管疾病,心血管疾病和心肌梗塞的死亡风险更高.
这些发现强调了在痛风管理中考虑心血管风险的重要性.

关键词:

心血管疾病是什么心血管疾病这是一种痛风,痛风.进行元分析分析.死亡率死亡率死亡率心肌梗塞的心脏病发作

更多相关视频

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

相关概念视频

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Exercise and Cardiovascular Response

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

Assessment of the Cardiovascular System I: Subjective Data

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...